Salivary Duct Carcinoma research hub

A phase 2 trial of capecitabine for recurrent and/or metastatic salivary duct carcinoma – CAESAR trial

This study is looking at a drug called capecitabine to see how well it works for people with a type of cancer called salivary duct carcinoma that has come back or spread. The main goal is to see if the cancer shrinks or stops growing.